1. Home
  2. IMNN vs CNVS Comparison

IMNN vs CNVS Comparison

Compare IMNN & CNVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Imunon Inc.

IMNN

Imunon Inc.

HOLD

Current Price

$1.05

Market Cap

7.9M

Sector

Health Care

ML Signal

HOLD

Logo Cineverse Corp.

CNVS

Cineverse Corp.

BUY

Current Price

$1.68

Market Cap

51.6M

ML Signal

BUY

Company Overview

Basic Information
Metric
IMNN
CNVS
Founded
1982
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Consumer Electronics/Video Chains
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
7.9M
51.6M
IPO Year
2000
2016

Fundamental Metrics

Financial Performance
Metric
IMNN
CNVS
Price
$1.05
$1.68
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
2
Target Price
★ $17.00
$11.50
AVG Volume (30 Days)
105.3K
★ 116.4K
Earning Date
11-12-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
★ $65,733,000.00
Revenue This Year
N/A
$80.42
Revenue Next Year
N/A
$13.15
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.96
$1.50
52 Week High
$5.03
$3.44

Technical Indicators

Market Signals
Indicator
IMNN
CNVS
Relative Strength Index (RSI) 35.10 12.62
Support Level $0.96 N/A
Resistance Level $1.59 $2.69
Average True Range (ATR) 0.08 0.11
MACD -0.00 -0.02
Stochastic Oscillator 22.62 12.87

Price Performance

Historical Comparison
IMNN
CNVS

About IMNN Imunon Inc.

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment of solid tumors. The second modality, PlaCCine, is developed for the coding of viral antigens that can elicit an immunological response. The company's clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer.

About CNVS Cineverse Corp.

Cineverse Corp is a technology and entertainment company. Its core business operates as a portfolio of owned and operated streaming channels with enthusiast fan bases; a large-scale aggregator and full-service distributor of feature films and television programs; and a proprietary technology software-as-a-service platform for over-the-top (OTT) app development and content distribution through subscription video-on-demand (SVOD), dedicated ad-supported (AVOD), ad-supported streaming linear (FAST) channels, social video streaming services, and audio podcasts. It generates revenue from streaming and digital, Base distribution, and audio podcasts, Podcast, Media services, and Other non-recurring. Its brands include Hallmark, ITV, Nelvana, ZDF, Konami, NFL, and Highlander.

Share on Social Networks: